Introduction
Patient spotlight
Table of contents
A message from our Chairman and Chief Executive Officer
Our mission and values
Boston Scientific: 2021 at a glance
Our ESG strategy 2021 highlights
Awards and recognition
Transforming care
Investing in our peopleAccelerating possibilitiesProtecting the environmentCreating value responsiblyAppendix
2
2021 Performance Report
Patient spotlight: Arnold Vargas Gonzalez
Not long after joining Boston Scientific, Arnold Vargas Gonzalez sensed it would be more than just a job. "The Boston Scientific quality culture inspired me right away," says the 39-year-old, who is based in Coyol, Costa Rica.
Arnold worked hard to progress from product builder to quality inspector, and with encouragement and support from his leaders and colleagues, he pursued a degree in industrial engineering to advance his career in quality.
After earning a promotion to quality engineer, Arnold suffered gallbladder complications, which led to a critical surgery. When doctors showed him the stent they were using, he knew he would make a full recovery. "I saw the Boston Scientific logo and it gave me such peace of mind. I believed in the device because we built it." Arnold was soon back on the quality front lines and to his studies.
Arnold and his wife Eimy, who also works in manufacturing at our Coyol site, are inspired to make life better for patients every day.
In 2021, amid global uncertainty, Arnold and his team stood strong - along with 41,000 Boston Scientific colleagues around the world. Across the company, our people innovated to improve patient outcomes, stay connected with customers and deliver solutions wherever they were needed.
The collective resolve of our global team accelerated our progress as a business and as a corporate citizen. We found new ways to support our communities, protect the environment we all share and make care more equitable.
Like Arnold, we believe - in the power of doing our part, always working for a better future and advancing science for life.
"I knew my future would be here, making our products - always with the patient in mind."
Arnold Vargas Gonzalez engineer,
Quality Assurance and Boston Scientific patient
Introduction
Patient spotlight
Table of contents
A message from our Chairman and Chief Executive Officer
Our mission and values
Boston Scientific: 2021 at a glance
Our ESG strategy 2021 highlights
Awards and recognition
Transforming care
Investing in our peopleAccelerating possibilitiesProtecting the environmentCreating value responsiblyAppendix
3
2021 Performance Report
Table of contents
This report has been prepared in reference to the Global Reporting Initiative guidelines and the SASB standards for the Medical Equipment & Supplies industry. Unless otherwise indicated, data in this 2021 Performance Report and appendix are as of December 31, 2021, or for the year ended December 31, 2021, as applicable. Please refer to the appendix for detailed metrics and key definitions used within this report. Reporting on other matters specific to financial performance of the company and its subsidiaries can be found in our 2021 Annual Report.
Patient spotlight: Arnold Vargas Gonzalez 2
A message from our Chairman
and Chief Executive Officer 4
Our mission and values 6
Boston Scientific: 2021 at a glance 7
Our ESG strategy: Advancing science for life 8
2021 highlights 11
Awards and recognition 12
Transforming care 13
Innovating to meet more patient needs 14
Ensuring quality, health and safety 17
Improving access and outcomes
through digital solutions 19
Investing in our people 20
Our diverse, equitable and inclusive workplace 21
Attracting, developing and retaining talent 25
Employee well-being, rewards and safety 28
Accelerating possibilities 31
Improving health equity and access 32
Confronting inequities 35
Supporting our communities 36
Protecting the environment 39
Reducing our environmental impact 40
Managing climate risk 45
Advancing product stewardship 46
Creating value responsibly 48
Good governance reflects our values 49
Compliance, ethics and integrity 50
Protecting human rights across our
company and supply chain 51
Keeping our supply chain resilient and reliable 52
Risk management and global security 53
Keeping our products and patient data secure 54
Appendix 55
Stakeholder engagement 56
Metrics summary 57
Global Reporting Initiative (GRI) index 68
Sustainability Accounting Standards Board
(SASB) index 75
United Nations Sustainable Development
Goals (SDGs) 77
Introduction
Patient spotlight
Table of contents
A message from our Chairman and Chief Executive Officer
Our mission and values
Boston Scientific: 2021 at a glance
Our ESG strategy 2021 highlights
Awards and recognition
Transforming care
Investing in our peopleAccelerating possibilitiesProtecting the environmentCreating value responsiblyAppendix
4
2021 Performance Report
At Boston Scientific, we have always been dedicated to advancing science for life. Now more than ever - at a time when we face continued challenges and uncertainty as a global community - we are hopeful and united by our mission and values to create a healthier, brighter future for one another and for our planet.
We remain confident in our progress and committed to transforming care, investing in our people, accelerating possibilities, protecting the environment and creating value responsibly. Our 2021 performance report is one example of our efforts to be transparent and accountable to the public and our many stakeholders. We are committed to understanding and managing environmental, social and governance (ESG) opportunities and risks in our business practices.
Overall, performance across Boston Scientific businesses remains strong and our future is promising. We've accomplished a great deal as we learned to manage through the pandemic. In 2021, we invested more than $1 billion in research and development and launched 90 new products to advance patient care. We strengthened our digital capabilities to enhance patient engagement to facilitate remote education and training for health care providers. Our teams conducted 145 global clinical trials and received approximately 1,250 market approvals that expand access to our technologies. Above all, we improved the lives of more than 30 million patients.
Introduction
Patient spotlight
Table of contents
A message from our Chairman and Chief Executive Officer
Our mission and values
Boston Scientific: 2021 at a glance
Our ESG strategy 2021 highlights
Awards and recognition
Transforming care
Investing in our peopleAccelerating possibilitiesProtecting the environmentCreating value responsiblyAppendix
5
2021 Performance Report
Addressing inequities in workplaces, communities and health care systems
The inequities in our workplaces, communities and health care systems have been starkly revealed over the last few years - by the pandemic, polarizing political environments, racial and social injustice and economic uncertainty. We have committed to support diversity, address health inequities and combat systemic racism and injustice both within Boston Scientific and our communities. In 2021, we made progress toward our goals by taking the following actions:
• Deepened our diversity programs aimed at eliminating bias, racism and other forms of discrimination in our workplace as part of our 3Up by 2023 initiative, which is aimed at increasing representation of women and multicultural talent at the management level.
• Introduced a human capital scorecard as part of our 2021 annual bonus program to hold ourselves accountable for building a more diverse and inclusive workplace and achieving our environmental goals.
• Expanded relationships with certified companies that share our dedication to improving customer and patient care, which included investing more than $865 million in small and diverse suppliers to help us meet our business objectives through external collaborations.
• Extended our advocacy across 28 national and local organizations as part of the second year of a $3.5 million multiyear strategy to combat inequity, systemic racism and injustice in the U.S.
• Increased diversity in medical research and partnered with community health care providers to expand awareness of health disparities and address them through our Close the Gap health equity initiative.
• Contributed more than $75 million in corporate donations to fund medical research, fellowships, education and charitable organizations globally.
1 Inclusive of all manufacturing and key distribution sites only.
2 Reflects adjustments to previously reported figure of 72% renewable electricity in our 2022 Annual Proxy Statement, based on subsequent internal audit.
Taking action for a healthier planet
By protecting the planet's health, we protect human health. That's why sustainable and inclusive business practices are central to our work to transform lives.
We are on track to achieve carbon neutrality by 2030 in all manufacturing and key distribution sites. In 2021, we committed to setting new science-based targets and reaching net-zero carbon emissions across our entire value chain by 2050.
So far, we've cut our energy usage by investing in and increasing energy efficiency at all of our sites. This includes new construction that meets the highest climate standards. Nearly half of Boston Scientific real estate - more than 4 million global square feet - currently meets International Organization for Standardization (ISO) and Leadership in Energy and Environmental Design (LEED) energy and environmental standards. We are also converting to renewable energy. In 2021, 73% of our electricity came from renewable sources (exceeding our interim goal of 50% by 2021) and we aim to source or generate 100% of our electricity from renewable sources by 2024.1,2 We are also pursuing efforts to better manage or reduce waste, conserve water and increase medical device recycling to minimize environmental impact of our products and packaging. To better protect our business and customers from climate-related disruption, our climate risk approach entails oversight, risk management and mitigation efforts throughout our business.
Creating a healthier, more equitable future
We have much work to do but we are making meaningful progress. The spirit and commitment of our global team has enabled us to succeed during uncertain times. We have a robust portfolio and pipeline, ambitious research and development, the highest quality standards and a deeply talented global team. Working together, we can continue to transform lives around the world through innovative medical solutions.
Chairman and Chief Executive Officer, Boston Scientific
Mike Mahoney
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Boston Scientific Corporation published this content on 03 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 May 2022 03:42:06 UTC.